Most recently, Celniker worked as the president and CEO of Taligen Therapeutics.
Before joining Taligen, Celniker was global head of biologics at Novartis, where she oversaw the biologics division, forged strategic alliances and led internal discovery and development to build the pipeline.
Prior to Novartis, she worked for Millennium Pharmaceuticals as senior vice president, R&D strategy and operations and head of biotherapeutics and pharmaceutical sciences.